Company · CIK 0000835887
PROGENICS PHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/APROGENICS PHARMACEUTICALS INC0000908834-22-000053 · 313.5 KBSEC(opens sec.gov)
- SC 13G/APROGENICS PHARMACEUTICALS INC0001214659-21-001720 · 296.8 KBSEC(opens sec.gov)
- SC 13D/APROGENICS PHARMACEUTICALS INC0001193125-20-176191 · 50.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-174778 · 110.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-171462 · 22.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-170487 · 35.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001437749-20-012911 · 22.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-163566 · 82.2 KBSEC(opens sec.gov)
- SC 13G/APROGENICS PHARMACEUTICALS INC0000790502-20-000009 · 8.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001437749-20-011934 · 24.7 KBSEC(opens sec.gov)
Insiders
- BAKER CHARLES ADirector
- Baker Mark RobertDirector, Chief Executive Officer
- Ber GerardDirector
- Boyd Thomas ASr. VP, Product Dev.
- BRINER KURT WDirector
- Broadfin Capital, LLC10% Owner
- Broadfin Healthcare Master Fund Ltd10% Owner
- Campbell Bradley LDirector
- Cooke Terence10% Owner, See Explanation of Responses
- Crowley Peter JDirector
Tickers
No tickers on record.
Addresses
business
ONE WORLD TRADE CENTER 47TH FLOOR
NEW YORK, NY, 10007
mailing
ONE WORLD TRADE CENTER 47TH FLOOR
NEW YORK, NY, 10007
Same industry